Sort   by:  
 Page size 
UnknownDoes Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Not available
S-EPMC5070573 | biostudies-literature
UnknownEmerging immunotherapies for malignant glioma: from immunogenomics to cell therapy.
Not available
S-EPMC7686464 | biostudies-literature
UnknownImmunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.
Not available
S-EPMC4625894 | biostudies-literature
UnknownNivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
Not available
S-EPMC8989388 | biostudies-literature
UnknownImmunotherapy response assessment in neuro-oncology: a report of the RANO working group.
Not available
S-EPMC4638131 | biostudies-literature
UnknownNeoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Not available
S-EPMC6408961 | biostudies-literature
UnknownA Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
Not available
S-EPMC11630866 | biostudies-literature
UnknownProton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma.
Not available
S-EPMC12648345 | biostudies-literature
UnknownA novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features.
Not available
S-EPMC3261728 | biostudies-literature
UnknownGlioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
Not available
S-EPMC7594557 | biostudies-literature
Sort   by:  
 Page size